SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks
Pharmos(PARS)
An SI Board Since November 1996
Posts SubjectMarks Bans Symbol
1491 8 0 PARS
Emcee:  Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1391 Dear David, I have thought long and hard about the question you asked me the oAriella-10/12/1998
1390 Dear Rick -- The Orphan Drug Act defines orphan products as ones used to treaAriella-10/12/1998
1389 FYI, AOL as its "Today's News" feature story, headlines the fullLLLefty-10/11/1998
1388 ABC News Less The Freezing, Save all the Pain of Searching... Immediately afteDavid Israel-Rosen-10/11/1998
1387 There were some studies that were monitored, which due to efficacy shown wereyosi s-10/11/1998
1386 N.I. thanks for answering my questions. As you can see the FDA is a bit of an eRick Strange-10/11/1998
1385 Wolfdog2, I went back to reread the ACB story and found that the link that I haRick Strange-10/11/1998
1384 Rick, thanks for posting the information about the ABC News story on dexanabinowolfdog2-10/10/1998
1383 1) Orphan drug status has advantages in terms of extending patent protection--bNeuroInvestment-10/10/1998
1382 Neruoinv, I agree with everything you said, except the comment about the two cOmer Shvili-10/10/1998
1381 Another HU-211 story from ABC News acbnews.com I read a very good AP story abRick Strange-10/10/1998
1380 N.I. Let me take a shot at playing Madison Avenue: 'HU-211 triples the likRick Strange-10/10/1998
1379 It is comforting to think an alternation in press release headlines would have Ariella-10/10/1998
1378 I agree that the 'HU211 triples likelihood of good outcome in severe head NeuroInvestment-10/9/1998
1377 Design of Phase III : From looking at the results of the phase II trial, I belOmer Shvili-10/9/1998
1376 David, I hope that in my last post I didn't seem insensitive to your positiwolfdog2-10/9/1998
1375 David: When in Israel with Prof. Aviv, in addition to your concerns about PR, yarnie h-10/9/1998
1374 DEAR TIM: THE DESIGN IS WELL OUT OF MY AREA OF EXPERTISE.I HAVE ALL THE CONFIDavid Israel-Rosen-10/9/1998
1373 YOSI: I COMPLETELY AGREE WITH YOUR 3 POINTS. IF THE RELEASE STATED JUST THADavid Israel-Rosen-10/9/1998
1372 There are several thoughts that I have about the design of phase III study forTimothy Kross-10/9/1998
1371 David my take on the release is three fold. 1. the decrease in ICP is very impyosi s-10/9/1998
1370 Ken: I agree that the next chance for a pop is when they sign a partner for tDavid Israel-Rosen-10/9/1998
1369 David, I think the mistake, if there was one, came much earlier when the companwolfdog2-10/9/1998
1368 As the following indicates we are not short on News. We are short on NOTICABLEDavid Israel-Rosen-10/9/1998
1367 Dear Ariella: How did we ned this week at $1.5 and not $3.0 ? I would like tDavid Israel-Rosen-10/9/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News